The World Health Organization has called for stricter regulation of nicotine pouches, warning that the tobacco industry is increasingly targeting young people with products that can deliver nicotine without combustion. The warning, reported by The BMJ on 15 May 2026, adds to growing concern about the appeal of newer nicotine products and the way they are marketed.
Nicotine pouches are typically placed between the gum and lip and do not involve smoking or vaping. But health experts say that the absence of smoke does not mean the products are harmless, especially when they are promoted in packaging and campaigns designed to attract adolescents and young adults. In its report, The BMJ said the WHO is pressing for tougher oversight as the tobacco industry widens its reach. ([bmj.com](https://www.bmj.com/specialties/general-practice-family-medicine?utm_source=openai))
Why regulators are watching the market closely
The push for tighter rules reflects broader concerns about how nicotine products are introduced to new consumers. Public health officials have long warned that products marketed as modern or discreet can still foster dependence, particularly among younger users who may view them as a lower-risk alternative to cigarettes. The BMJ’s coverage places the issue in the context of ongoing efforts to limit youth exposure to nicotine. ([bmj.com](https://www.bmj.com/specialties/general-practice-family-medicine?utm_source=openai))
The WHO’s call comes as health systems and regulators continue to monitor how tobacco-related products evolve faster than policy responses. For clinicians, educators and parents, the debate is not only about smoking cessation but also about whether nicotine pouches may create a new pathway into addiction. ([bmj.com](https://www.bmj.com/specialties/general-practice-family-medicine?utm_source=openai))
Public health concern extends beyond smoking
The report underscores a familiar theme in health policy: when one nicotine product becomes less socially acceptable, manufacturers often shift toward alternatives that appear cleaner or less harmful. That does not remove the need for scrutiny, especially if the marketing is directed at groups most vulnerable to addiction. ([bmj.com](https://www.bmj.com/specialties/general-practice-family-medicine?utm_source=openai))
As the discussion continues, regulators in the UK and elsewhere are likely to face pressure to decide whether existing rules are enough to keep pace with the changing nicotine market. For now, the WHO’s message is clear: new products may look different from cigarettes, but they still warrant close attention from public health authorities. ([bmj.com](https://www.bmj.com/specialties/general-practice-family-medicine?utm_source=openai))
